100 related articles for article (PubMed ID: 20211620)
21. Janus kinase 3: a novel target for selective transplant immunosupression.
Podder H; Kahan BD
Expert Opin Ther Targets; 2004 Dec; 8(6):613-29. PubMed ID: 15584866
[TBL] [Abstract][Full Text] [Related]
22. Janus kinase 3 regulates interleukin 2-induced mucosal wound repair through tyrosine phosphorylation of villin.
Kumar N; Mishra J; Narang VS; Waters CM
J Biol Chem; 2007 Oct; 282(42):30341-5. PubMed ID: 17537734
[TBL] [Abstract][Full Text] [Related]
23. Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells.
Nagy ZS; Ross JA; Rodriguez G; Balint BL; Szeles L; Nagy L; Kirken RA
PLoS One; 2013; 8(2):e57326. PubMed ID: 23451206
[TBL] [Abstract][Full Text] [Related]
24. In vivo impact of JAK3 A573V mutation revealed using zebrafish.
Basheer F; Bulleeraz V; Ngo VQT; Liongue C; Ward AC
Cell Mol Life Sci; 2022 May; 79(6):322. PubMed ID: 35622134
[TBL] [Abstract][Full Text] [Related]
25. Insights into kinetic mechanism of Janus kinase 3 and its inhibition by tofacitinib.
Hekmatnejad M; Conwell S; Lok SM; Kutach A; Shaw D; Fang E; Swinney DC
Arch Biochem Biophys; 2016 Dec; 612():22-34. PubMed ID: 27555492
[TBL] [Abstract][Full Text] [Related]
26. Targeting JAK3 tyrosine kinase-linked signal transduction pathways with rationally-designed inhibitors.
Uckun FM; Vassilev A; Dibirdik I; Tibbles H
Anticancer Agents Med Chem; 2007 Nov; 7(6):612-23. PubMed ID: 18045056
[TBL] [Abstract][Full Text] [Related]
27. Jak3-regulated genes: DNA array analysis of concanavalin a-interleukin-2-activated chicken T cells treated with a specific jak3 inhibitor.
Kampa D; Burnside J
J Interferon Cytokine Res; 2002 Sep; 22(9):975-80. PubMed ID: 12396719
[TBL] [Abstract][Full Text] [Related]
28. JAK3 pathway is constitutively active in B-lineage acute lymphoblastic leukemia.
Uckun FM; Pitt J; Qazi S
Expert Rev Anticancer Ther; 2011 Jan; 11(1):37-48. PubMed ID: 21070101
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activity.
Cheng H; Ross JA; Frost JA; Kirken RA
Mol Cell Biol; 2008 Apr; 28(7):2271-82. PubMed ID: 18250158
[TBL] [Abstract][Full Text] [Related]
30. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
Zhang YW; Jiang XX; Chen QS; Shi WY; Wang L; Sun HD; Shen ZX; Chen Z; Chen SJ; Zhao WL
Exp Hematol; 2010 Mar; 38(3):191-201. PubMed ID: 20045442
[TBL] [Abstract][Full Text] [Related]
31. Identification of mutant alleles of JAK3 in pediatric patients with acute lymphoblastic leukemia.
Yin C; Sandoval C; Baeg GH
Leuk Lymphoma; 2015 May; 56(5):1502-6. PubMed ID: 25146434
[TBL] [Abstract][Full Text] [Related]
32. FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma.
Elliott NE; Cleveland SM; Grann V; Janik J; Waldmann TA; Davé UP
Blood; 2011 Oct; 118(14):3911-21. PubMed ID: 21821710
[TBL] [Abstract][Full Text] [Related]
33. Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL.
Degryse S; Bornschein S; de Bock CE; Leroy E; Vanden Bempt M; Demeyer S; Jacobs K; Geerdens E; Gielen O; Soulier J; Harrison CJ; Constantinescu SN; Cools J
Blood; 2018 Jan; 131(4):421-425. PubMed ID: 29187379
[TBL] [Abstract][Full Text] [Related]
34. JAK3: a two-faced player in hematological disorders.
Cornejo MG; Boggon TJ; Mercher T
Int J Biochem Cell Biol; 2009 Dec; 41(12):2376-9. PubMed ID: 19747563
[TBL] [Abstract][Full Text] [Related]
35. PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression.
Yuan S; Wang X; Hou S; Guo T; Lan Y; Yang S; Zhao F; Gao J; Wang Y; Chu Y; Shi J; Cheng T; Yuan W
Leukemia; 2022 Feb; 36(2):370-382. PubMed ID: 34465864
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanism of interleukin-2-induced mucosal homeostasis.
Mishra J; Waters CM; Kumar N
Am J Physiol Cell Physiol; 2012 Mar; 302(5):C735-47. PubMed ID: 22116305
[TBL] [Abstract][Full Text] [Related]
37. Permission to proceed: Jak3 and STAT5 signaling molecules give the green light for T helper 1 cell differentiation.
Murphy KM
Immunity; 2008 Jun; 28(6):725-7. PubMed ID: 18549792
[TBL] [Abstract][Full Text] [Related]
38. Are peptides a solution for the treatment of hyperactivated JAK3 pathways?
Dullius A; Rocha CM; Laufer S; de Souza CFV; Goettert MI
Inflammopharmacology; 2019 Jun; 27(3):433-452. PubMed ID: 30929155
[TBL] [Abstract][Full Text] [Related]
39. Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors.
Martinez GS; Ross JA; Kirken RA
Clin Cancer Drugs; 2016; 3(2):131-137. PubMed ID: 29046866
[TBL] [Abstract][Full Text] [Related]
40. A Targeted Quantitative Proteomic Method Revealed a Substantial Reprogramming of Kinome during Melanoma Metastasis.
Miao W; Li L; Liu X; Qi TF; Guo L; Huang M; Wang Y
Sci Rep; 2020 Feb; 10(1):2485. PubMed ID: 32051510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
